<DOC>
	<DOC>NCT03068377</DOC>
	<brief_summary>Objectives: To determine LYC-001e's influences on ocular blood flow Ocular blood flow has been implicated as a parameter relevant to eye health and involved in the disease process of several ophthalmic pathologies including AMD, glaucoma, and diabetes we hypothesis that LYC-001e will increase measures of ocular blood flow in healthy individuals Methods: This is a single-phase, randomized, parallel, double blind , comparative study of LYC-001e versus placebo on ocular blood vessels in healthy individuals.</brief_summary>
	<brief_title>The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<criteria>Healthy males and females of 18 years of age or older and free of any eye disease (other than myopia) Willing to sign an informed consent statement and able to comply with the requirements of the examination Women who are pregnant or lactating or who plan to become pregnant (self reporting) within the duration of the study or within one month after study completion. Receiving medications or dietary supplements known to have any interaction with the study supplements. Smoker during last ten years (self reporting) Concurrent use of any of the components of the study supplement Individuals with narrow anterior chamber angles</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>lycopene</keyword>
	<keyword>eye</keyword>
</DOC>